Bright Minds Biosciences (DRUG) Equity Ratio (2021 - 2026)
For the quarter ending Q1 2026, Equity Ratio changed N/A year-over-year to 1.17, compared with a TTM value of 1.17 through Mar 2026, changed N/A, and an annual FY2025 reading of 1.46, down 74.84% over the prior year.
Bright Minds Biosciences (DRUG) has disclosed Equity Ratio for 3 consecutive years, with 1.17 as the latest value for Q1 2026.
- Equity Ratio reached 1.17 in Q1 2026 per DRUG's latest filing, down from 1.46 in the prior quarter.
- Across five years, Equity Ratio topped out at 5.8 in Q3 2024 and bottomed at 1.17 in Q1 2026.
- Average Equity Ratio over 3 years is 2.81, with a median of 1.46 recorded in 2025.
- The widest YoY moves for Equity Ratio: up 74.84% in 2025, down 74.84% in 2025.
- Bright Minds Biosciences' Equity Ratio stood at 5.8 in 2024, then crashed by 74.84% to 1.46 in 2025, then dropped by 19.79% to 1.17 in 2026.
- Per Business Quant, the three most recent readings for DRUG's Equity Ratio are 1.17 (Q1 2026), 1.46 (Q3 2025), and 5.8 (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 0.73 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 0.77 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 0.21 |
| 10 | Bright Minds Biosciences | 464.72 Mn | 405.19 Mn | - | 1.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.17 |
| Dec 31, 2025 | 0.98 |
| Sep 30, 2025 | 0.97 |
| Jun 30, 2025 | 1.71 |
| Mar 31, 2025 | 0.99 |
| Dec 31, 2024 | 1.52 |
| Sep 30, 2024 | 5.80 |
| Jun 30, 2024 | 0.97 |
| Mar 31, 2024 | 5.37 |
| Dec 31, 2023 | 5.09 |
| Sep 30, 2023 | 0.96 |
| Jun 30, 2023 | 0.91 |
| Mar 31, 2023 | 0.90 |
| Dec 31, 2022 | 0.95 |
| Sep 30, 2022 | 0.87 |
| Jun 30, 2022 | 0.96 |
| Mar 31, 2022 | 0.91 |
| Dec 31, 2021 | 0.97 |
| Sep 30, 2021 | 0.97 |